Coronavirus (COVID-19) resources

Hepatitis B immune globulin for preventing hepatitis B recurrence after liver transplantation

We aim to assess the benefits and harms of HBIg after liver transplantation in HBV-infected patients.

We will try to find the minimal effective dose and time of the HBIg treatment in order to reduce the adverse effects as well as cost of the treatment.

This is a protocol.

You may also be interested in:

Hepatitis B immunoglobulin (HBIG) during pregnancy for the prevention of mother-to-child transmission of hepatitis B virus (HBV)
Hepatitis B vaccine, hepatitis B immunoglobulin, and hepatitis B vaccine plus immunoglobulin prevent perinatal transmission of hepatitis B
Immunoglobulins (human serum immune gamma globulins) seem effective for prevention of hepatitis A
Vaccines for preventing hepatitis B in healthcare workers (an updated protocol)
Bile acids may improve liver biochemistry of patients with hepatitis B or C, but there is insufficient evidence about long-term beneficial effects

Health topics:

Gastroenterology & hepatology > Liver disorders > Transplantation

Gastroenterology & hepatology > Liver disorders > Hepatitis B

Infectious disease > Liver infections > Hepatitis B

Published:

17 October 2012

Authors:

Berdichevski T, Kumar S, Katz LH

Primary Review Group:

Hepato-Biliary Group

See the full Review on

the Cochrane Library

Print
PDF
Citation
Berdichevski T, Kumar S, Katz LH. Hepatitis B immune globulin for preventing hepatitis B recurrence after liver transplantation. Cochrane Database of Systematic Reviews 2012, Issue 10. Art. No.: CD010174. DOI: 10.1002/14651858.CD010174